Crowne Plaza Seattle Downtown
1113 6th Avenue
Seattle, WA 98101

Registration Fee
There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
A discounted self-parking rate of $16.00 is available at the hotel.

Program Summary

Primary care providers face complex challenges every day in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

At the conclusion of this program, participants should be able to:

1. Describe nocturia’s impact on affected patients; Evaluate symptoms of nocturia in affected patients in order to determine the source of symptoms; Assess current pharmacologic and non-pharmacologic nocturia management strategies; Differentiate the mechanisms of action, and safety and efficacy profiles of available and emerging therapies for nocturia.
2. Review the pathophysiology of atherosclerotic cardiovascular disease (ASCVD) and congestive heart failure (CHF) in T2DM; Recognize how the mechanism of action of the SGLT-2 inhibitor class can potentially have a beneficial impact on cardio-renal disease; Discuss CVOTs to date in T2DM and the impact of the SGLT-2 inhibitor class on improving cardiovascular outcomes and preventing progression of chronic kidney disease (CKD); Incorporate evolving clinical data into the management of diabetes in patients with, or at high risk for, cardiovascular disease (CVD).
3. Explain and apply CDC and other guidelines for initiating treatment for influenza in specific patient populations; Assess new and emerging antiviral therapies profiles used to treat influenza; Demonstrate effective communication techniques to address perceptions of symptom severity, vaccination measures, and therapeutic safety and efficacy.
4. Assess the clinical impact of herpes zoster and postherpetic neuralgia; Evaluate the efficacy, tolerability, and safety of available vaccines to prevent herpes zoster; Develop effective strategies to promote adherence to national vaccine guidelines.
5. Describe the neurochemistry and physiology of normal sleep; Recognize and discuss with the patient the impact sleep deprivation; Identify sleep parasomnias by movement and behavioral histories and reports; Implement tools for clinical assessment of sleep-wake disorders in primary care; Discuss both “Smart Goals” and individualized treatment options for deprivation and parasomnias in the primary care setting.

Agenda*

7:30-8:00 am
Continental Breakfast and Registration

8:00-8:10
Welcome Remarks – Bill Davies, PAC, BS, RRT

8:10-9:20
Identification, Evaluation, and Treatment of Nocturia in the Primary Care Setting in 2019
Matt T. Rosenberg, MD

9:20-10:30
Individualizing Diabetes Care-The Impact of CV Risk on Therapeutic Strategy
Mark Stolar, MD

10:30-10:50
Break

10:50-12:00 pm
What’s New with the Flu?
Charles P. Vega, MD

12:00-1:10
Lunch

1:10-2:20
Addressing Unmet Needs in Herpes Zoster: Sharing Strategies to Improve Care
Charles P. Vega, MD

2:20-3:30
Sleep and Parasomnias in Primary Care
Bill Davies, PAC, BS, RRT

3:30-3:45
Summary of Key Points and Closing Remarks – Bill Davies, PAC, BS, RRT

* Agenda subject to change

Faculty

Bill P. Davies, PA-C, RRT
Division of Pulmonary and Sleep Medicine
Confluence Health
Wenatchee, WA

Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI

Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL

Charles Vega MD Clinical Professor, Family Medicine
Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC), Family Medicine
School of Medicine Associate Dean for Diversity and Inclusion
School of Medicine
Irvine, CA

Moderator

Bill P. Davies, PA-C, RRT
Division of Pulmonary and Sleep Medicine
Confluence Health
Wenatchee, WA